000 01563 a2200421 4500
005 20250511193809.0
264 0 _c19920714
008 199207s 0 0 eng d
022 _a0006-3223
024 7 _a10.1016/0006-3223(92)90276-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan Kempen, G M
245 0 0 _aBiochemical measures in patients with a somatoform pain disorder, before, during, and after treatment with amitriptyline with or without flupentixol.
_h[electronic resource]
260 _bBiological psychiatry
_cApr 1992
300 _a670-80 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAmitriptyline
_xadministration & dosage
650 0 4 _aDepressive Disorder
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFlupenthixol
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethoxyhydroxyphenylglycol
_xanalogs & derivatives
650 0 4 _aMiddle Aged
650 0 4 _aPain
_xblood
650 0 4 _aPain Measurement
650 0 4 _aPersonality Inventory
650 0 4 _aSerotonin
_xblood
650 0 4 _aSomatoform Disorders
_xblood
700 1 _aZitman, F G
700 1 _aLinssen, A C
700 1 _aEdelbroek, P M
773 0 _tBiological psychiatry
_gvol. 31
_gno. 7
_gp. 670-80
856 4 0 _uhttps://doi.org/10.1016/0006-3223(92)90276-6
_zAvailable from publisher's website
999 _c1606466
_d1606466